How to Reduce Calcium Plaque in Arteries

Once calcium has been deposited inside artery walls, no widely proven therapy can scrub it away. That is the frustrating reality facing anyone who gets back a coronary artery calcium (CAC) score and wants to undo the damage. What medicine can do, however, is slow the rate at which calcification progresses, lower the cardiovascular risk that comes with it, and in some cases change the character of the plaque so it is less likely to rupture. The distinction between reversing a calcium score and actually reducing your chance of a heart attack turns out to be one of the most misunderstood topics in cardiology.

Why Calcium Builds Up in Arteries

Arterial calcification is not random mineral sludge clogging a pipe. It is a biologically regulated process that resembles bone formation in some unsettling ways. The cells that line artery walls, known as vascular smooth muscle cells, can shift into an “osteochondrogenic” state, essentially behaving like bone-forming cells. In mouse studies using genetic tracking, roughly 98 percent of the bone-like cells found inside plaques originated from these smooth muscle cells.¹ Once switched on, they start producing the same structural proteins that build bone and release tiny vesicles that seed calcium crystals in the vessel wall.²

There are also two distinct locations where calcium can accumulate. In atherosclerosis, calcium shows up inside plaques in the inner lining of arteries, typically in more advanced disease. A separate process deposits calcium in the middle layer of the artery wall, which tends to appear earlier and is more strongly linked to diabetes and to the progressive narrowing of small vessels.³ This matters because strategies aimed at one type may not help the other, and a standard CT calcium scan cannot always distinguish between them.

What Your Calcium Score Tells You

A coronary artery calcium score, measured by a quick, low-dose CT scan, gives a number that reflects the total amount of calcified plaque in your coronary arteries. A score of zero is reassuring. Scores above 100 are associated with a meaningfully higher risk of heart disease events across all racial and ethnic groups.⁴ In a large multi-ethnic study, people with scores between 101 and 300 had nearly eight times the risk of a coronary event compared to those with no calcium, and scores above 300 pushed that to almost ten times the risk.⁵ Adding the calcium score to traditional risk factors consistently improves doctors’ ability to predict who will have a heart attack, which is why it is increasingly used to guide decisions about preventive treatments like statins.⁶

The number itself, though, can be misleading if you fixate on making it go down rather than on reducing overall risk. A rising calcium score does not always mean things are getting worse, and this is where the statin story gets interesting.

The Statin Paradox

Statins are the most proven drug class for preventing heart attacks and strokes. They lower LDL cholesterol, stabilize plaques, and reduce cardiovascular events across large populations. Yet a growing body of evidence shows that statin users tend to accumulate more coronary calcium over time, not less.⁷ Imaging studies using detailed CT analysis found that statins were associated with increases in dense calcium deposits within plaques, while at the same time reducing the softer, more dangerous fatty components.⁸

Think of it this way: a plaque filled with soft, lipid-rich material is like a thin-skinned blister that can burst, triggering a clot. Calcification stiffens and stabilizes that plaque, making rupture less likely. So statins may be converting dangerous plaques into more stable ones, and the calcium score goes up as a side effect of that beneficial remodeling. The score looks worse on paper, but the arteries are actually safer. This is one of the strongest arguments against chasing a lower number for its own sake.

An alternative lipid-lowering class, PCSK9 inhibitors, appears to slow calcium accumulation more than statins do. In one study comparing the PCSK9 inhibitor alirocumab to standard statin therapy, calcium scores in the statin group rose by about 11 percent while scores in the alirocumab group rose by only about 3 percent.⁹ Whether this translates to additional clinical benefit beyond what statins already provide is not yet clear, but it is a pattern researchers are watching.

Nutrients That Influence Calcification

Several nutrients play roles in keeping calcium where it belongs (in bones) rather than where it does not belong (in arteries). The evidence for most of them is strongest in laboratory and animal studies, with human trials still catching up, but the biological rationale is solid enough that researchers and clinicians take them seriously.

Vitamin K

Vitamin K activates a protein called matrix Gla protein, or MGP, which acts as one of the body’s main brakes on arterial calcification.¹⁰ Without enough vitamin K, MGP stays inactive, and the brake is essentially off. Vitamin K1 comes primarily from leafy greens, while vitamin K2, the form more closely studied for vascular effects, is found in fermented foods like certain cheeses and natto (fermented soybeans).¹¹ Inactive MGP levels in the blood have been associated with greater prevalence of medial artery calcification.¹²

This connection has led to clinical trials testing whether vitamin K2 supplements can slow calcification. Early results are mixed, and no major cardiology guideline yet recommends K2 supplements specifically for this purpose. But the biological logic is straightforward: adequate vitamin K keeps one of the body’s key anti-calcification proteins working. People on blood thinners like warfarin, which blocks vitamin K activity, should be aware that this drug essentially disables MGP and has been linked to accelerated vascular calcification. That does not mean you should stop warfarin without medical guidance, but it is part of why newer anticoagulants that do not interfere with vitamin K are sometimes preferred.

Magnesium

In laboratory experiments, magnesium directly prevents the formation of hydroxyapatite, the crystalline form of calcium that makes up arterial deposits. When researchers added magnesium to cell cultures treated with high phosphate levels, the calcium crystals simply did not form, and the effect appeared to work by blocking crystal growth in the fluid surrounding cells rather than by changing what the cells themselves were doing.¹³ Magnesium is one of the nutraceuticals with the most preclinical and early clinical data supporting a role in slowing vascular calcification.¹⁴ Since many people consume less magnesium than recommended, correcting a deficiency is a low-risk starting point.

Vitamin D

Vitamin D and arterial calcification have a complicated relationship. Active vitamin D levels have been found to be inversely correlated with the extent of vascular calcification, meaning lower levels were associated with more calcium in artery walls.¹⁵ But that does not mean that megadosing vitamin D will help. Disruptions in vitamin D metabolism, combined with unbalanced dietary calcium and impaired mineral handling by the kidneys, can actually promote calcification.¹⁶ A randomized trial of high-dose vitamin D supplementation found no difference in arterial calcification progression between the supplement group and controls.¹⁷ The takeaway: maintaining healthy vitamin D levels makes sense, but high-dose supplements aimed specifically at calcification are not supported by trial data.

Diet, Exercise, and the Mediterranean Pattern

A large German cohort study tracked dietary patterns and calcium score progression over five years and found that people eating a Mediterranean-style diet had roughly 40 percent lower risk of rapid calcium score progression compared to those eating a diet high in animal fat and alcohol. The association held for both men and women.¹⁸ A Mediterranean pattern is rich in vegetables, legumes, fish, olive oil, and whole grains, which naturally delivers vitamin K, magnesium, and other compounds relevant to vascular health. It is probably the single dietary strategy with the strongest observational support for slowing calcification.

Exercise adds another layer of nuance. Regular physical activity reduces nearly every cardiovascular risk factor and is firmly recommended. But a consistent finding in research over the past two decades is that older men who have done very high volumes of endurance exercise across their lifetimes tend to have higher coronary calcium scores than you would expect.¹⁹ The clinical meaning of this is not fully settled, because these athletes still tend to have low rates of heart attacks. It may be another instance where calcium in plaque reflects stabilization rather than danger. Moderate, consistent exercise remains one of the most effective things you can do for your arteries. The observation about extreme endurance training is a research curiosity, not a reason to skip your morning run.

The Kidney Connection

Chronic kidney disease (CKD) deserves special mention because it dramatically accelerates arterial calcification. When the kidneys cannot properly regulate calcium and phosphate levels in the blood, both minerals rise and directly stimulate smooth muscle cells to take on that bone-forming behavior.²⁰ High phosphate drives the osteogenic switch, while elevated calcium promotes cell death and the release of calcification-seeding vesicles, and when both are high simultaneously, the effects are greater than either alone.²¹

For people with kidney disease, managing phosphate through diet and phosphate binders, keeping calcium supplements to recommended levels, and treating underlying mineral imbalances is a direct strategy for slowing vascular calcification. Much of the therapeutic research on calcification, in fact, comes from the nephrology world, where the problem is most severe and most urgent.

The Gut Microbiome and TMAO

An unexpected player in vascular calcification is trimethylamine N-oxide, or TMAO, a compound produced when gut bacteria metabolize nutrients found in red meat, eggs, and certain fish. In both cell and animal studies, TMAO promoted calcium deposition in artery walls in a dose-dependent fashion, meaning more TMAO led to more calcification. It did this by pushing smooth muscle cells toward that osteogenic state and by triggering inflammatory signaling pathways. In rats with kidney disease, reducing TMAO levels with antibiotics actually slowed vascular calcification.²²

Nobody is going to take antibiotics to lower TMAO, but the finding points to the gut microbiome as a modifiable factor. Diets lower in red meat and higher in fiber tend to produce less TMAO. This is yet another mechanism through which a Mediterranean-style eating pattern could help, beyond just delivering the right nutrients.

Experimental Therapies Under Investigation

Researchers are exploring several approaches that go beyond lifestyle and standard medications. None of these are ready for routine clinical use, but they represent the frontiers of the field.

Sodium thiosulfate (STS), an intravenous compound already used for some rare calcification-related conditions, has been tested in hemodialysis patients. A meta-analysis of available studies found that STS-treated patients showed notably less progression in coronary and iliac artery calcium scores compared to controls, along with less arterial stiffening.²³ Animal studies found that thiosulfate-treated rats with kidney failure showed no aortic calcification, while nearly three-quarters of untreated rats did, likely because STS enhanced calcium excretion through the kidneys.²⁴ Pilot human studies have judged it feasible and apparently safe, but larger randomized trials are needed.²⁵

SNF472, a drug derived from inositol hexaphosphate (phytate), works by binding directly to the surface of hydroxyapatite crystals and blocking their growth. In animal studies, treated rats had aortic calcium levels about 38 percent lower than untreated controls.²⁶ Phytate itself is found in whole grains and legumes, and it is one of the nutraceuticals flagged for further study in cardiovascular calcification research.¹⁴

There is also an older, more controversial line of investigation using EDTA-based chelation therapy. One trial reported that about 57 percent of patients treated with a combination therapy including EDTA showed decreased coronary calcium scores, with an average reduction of about 14 percent among those who responded.²⁷ But 44 percent of patients saw no change or worsening, and chelation therapy remains outside mainstream cardiology guidelines. It has vocal supporters in alternative medicine circles, but the evidence base is thin enough that most cardiologists do not recommend it.

When Calcium Needs to Be Physically Dealt With

In severe cases where heavily calcified arteries need to be opened, interventional cardiologists have a growing toolkit. Intravascular lithotripsy (IVL), adapted from the technology used to break up kidney stones, delivers focused acoustic pressure waves inside the artery to fracture calcium deposits, making the vessel more flexible so that stents can be properly placed.²⁸ Clinical studies have confirmed the technique’s ability to crack calcium and allow successful stent deployment in arteries that would otherwise resist treatment.²⁹ This is not a strategy for reducing your calcium score, though. It is a way to manage the mechanical consequences of calcification when blood flow is critically compromised.

The Body’s Own Anti-Calcification System

Your body is not defenseless against stray calcium deposits. Beyond MGP (the vitamin K-dependent protein discussed earlier), a circulating protein called fetuin-A acts as a second major line of defense. Fetuin-A grabs free calcium and phosphate in the bloodstream and bundles them into soluble particles that can be safely cleared, preventing them from precipitating into artery walls. Estimates suggest fetuin-A accounts for roughly half of the blood’s ability to prevent unwanted calcium-phosphate precipitation. People with chronic kidney disease often have reduced fetuin-A levels, which partly explains their vulnerability to severe vascular calcification.³⁰

Understanding these natural inhibitors reframes the problem. Arterial calcification is not simply about having too much calcium in your diet. It is about whether the protective systems that normally keep calcium out of soft tissues are functioning properly. Vitamin K status, phosphate balance, kidney function, and proteins like fetuin-A all factor in. Interventions that support these natural defenses may be more effective than trying to remove calcium that has already been laid down.

Imaging That Catches Calcification Before It Shows on CT

Standard CT scans only detect calcium deposits once they have grown into dense, macroscopic chunks. A newer imaging technique using a radiotracer called 18F-sodium fluoride (18F-NaF) in PET/CT scans can detect microcalcification, the earliest phase of calcium crystal formation, before it becomes visible on conventional imaging.³¹ In one case, this technique identified active microcalcification in a 17-year-old patient who had no calcium visible at all on standard CT.³² It has also revealed active calcification at arterial sites that appeared clean on CT.³³

This matters for the future of treatment because it shifts the focus from established calcium to active calcification. If you can identify which plaques are actively mineralizing right now, you can target interventions more precisely and measure their effects over shorter timeframes than waiting for calcium scores to change on conventional CT. The technology is still primarily a research tool, but it is shaping how trials of anti-calcification therapies are designed and may eventually guide personalized treatment decisions.